Biopharma venture capital fundraising declined from $8.1 billion in the first quarter of 2024 to $6.5 billion in the first ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...

Vertex has recorded some 25,000 prescriptions for Journavx since its January approval and is in the process of getting big ...

Twenty attorneys general allege that the recent workforce reduction at the Department of Health and Human Services is ...

The biotech’s Huntingtin-targeting molecule lowered blood levels of the protein and elicited functional improvements in ...

Bristol Myers Squibb has made significant cuts to its workforce since last year as part of a strategic reorganization aimed ...

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...